soyasaponin bb has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bureau, DP; Collins, FW; Holub, BJ; Philbrick, DJ | 1 |
Han, M; Heo, H; Hong, SW; Kim, DH; Kwon, YK; Yang, JH | 1 |
Cao, W; Guo, Z; Han, B; Han, Z; Zhao, S | 1 |
3 other study(ies) available for soyasaponin bb and Disease Models, Animal
Article | Year |
---|---|
Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease.
Topics: Animal Feed; Animals; Body Weight; Caseins; Dietary Supplements; Disease Models, Animal; Isoflavones; Kidney; Male; Mice; Mice, Mutant Strains; Organ Size; Polycystic Kidney Diseases; Saponins; Soybean Proteins; Water | 2003 |
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats.
Topics: Animals; Behavior, Animal; Biomarkers; Cell Differentiation; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Hippocampus; Ibotenic Acid; Male; Memory; Memory Disorders; Microglia; Nerve Regeneration; Neural Stem Cells; Neurons; Neuroprotective Agents; Oleanolic Acid; Pregnancy; Rats; Rats, Sprague-Dawley; Saponins | 2013 |
Protection against 1-methyl-4-phenyl pyridinium-induced neurotoxicity in human neuroblastoma SH-SY5Y cells by Soyasaponin I by the activation of the phosphoinositide 3-kinase/AKT/GSK3β pathway.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Humans; Neuroprotective Agents; Oleanolic Acid; Parkinson Disease; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Saponins; Signal Transduction | 2016 |